Serhan CN - Search Results

1

WITHDRAWN: The Atlas of Inflammation Resolution (AIR).

Serhan CN, Gupta SK, Perretti M, Godson C, Brennan E, Li Y, Soehnlein O, Shimizu T, Werz O, Chiurchiù V, Azzi A, Dubourdeau M, Gupta SS, Schopohl P, Hoch M, Gjorgevikj D, Khan FM, Brauer D, Tripathi A, Cesnulevicius K, Lescheid D, Schultz M, Särndahl E, Repsilber D, Kruse R, Sala A, Haeggström JZ, Levy BD, Filep JG, Wolkenhauer O. Serhan CN, et al. Mol Aspects Med. 2020 Aug 29:100893. doi: 10.1016/j.mam.2020.100893. Online ahead of print. Mol Aspects Med. 2020. PMID: 32873427

2

Cell-cell interactions in lipoxin generation and characterization of lipoxin A4 receptors.

Serhan CN, Fiore S, Levy BD. Serhan CN, et al. Ann N Y Acad Sci. 1994 Nov 15;744:166-80. doi: 10.1111/j.1749-6632.1994.tb52734.x. Ann N Y Acad Sci. 1994. PMID: 7825838 Review. No abstract available.

3

Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA.

Levy BD, Bertram S, Tai HH, Israel E, Fischer A, Drazen JM, Serhan CN. Levy BD, et al. Among authors: serhan cn. Lipids. 1993 Dec;28(12):1047-53. doi: 10.1007/BF02537069. Lipids. 1993. PMID: 8121246 Clinical Trial.

4

Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins.

Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN. Levy BD, et al. Among authors: serhan cn. J Clin Invest. 1993 Sep;92(3):1572-9. doi: 10.1172/JCI116738. J Clin Invest. 1993. PMID: 8376607 Free PMC article.

5

Lipid mediator networks in cell signaling: update and impact of cytokines.

Serhan CN, Haeggström JZ, Leslie CC. Serhan CN, et al. FASEB J. 1996 Aug;10(10):1147-58. doi: 10.1096/fasebj.10.10.8751717. FASEB J. 1996. PMID: 8751717 Review.

6

Polyisoprenyl phosphates in intracellular signalling.

Levy BD, Petasis NA, Serhan CN. Levy BD, et al. Among authors: serhan cn. Nature. 1997 Oct 30;389(6654):985-90. doi: 10.1038/40180. Nature. 1997. PMID: 9353124

7

Agonist-induced lipoxin A4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA.

Levy BD, Drazen JM, Serhan CN. Levy BD, et al. Among authors: serhan cn. Adv Exp Med Biol. 1997;400B:611-5. Adv Exp Med Biol. 1997. PMID: 9547611 Clinical Trial. No abstract available.

8

Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4.

Levy BD, Fokin VV, Clark JM, Wakelam MJ, Petasis NA, Serhan CN. Levy BD, et al. Among authors: serhan cn. FASEB J. 1999 May;13(8):903-11. doi: 10.1096/fasebj.13.8.903. FASEB J. 1999. PMID: 10224233

9

Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions.

Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN. Filep JG, et al. Among authors: serhan cn. Blood. 1999 Dec 15;94(12):4132-42. Blood. 1999. PMID: 10590058 Free article.

10

A novel polyisoprenyl phosphate signaling cascade in human neutrophils.

Levy BD, Serhan CN. Levy BD, et al. Among authors: serhan cn. Ann N Y Acad Sci. 2000 Apr;905:69-80. doi: 10.1111/j.1749-6632.2000.tb06539.x. Ann N Y Acad Sci. 2000. PMID: 10818443 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

611 results

Search Page